Latest Post

August 19, 2020

How are you responding to pharmacopoeia expectation of parenteral preparations?

Regulatory agencies are driving the pharmaceutical industry to continuously improve the quality of drug products, but what is the reality for a drug developer who is expected to make parenteral preparations “practically free from particles”? Expectations of packaging are changing fast but how well prepared is the packaging to meet these needs?
Victoria Morgan

Victoria Morgan

Director, Global Marketing, Biologics


Search the Blog